What patents cover divalproex sodium 500 mg?
Divalproex sodium tablets (including 500 mg) are typically considered a generic-competition area, where the key question is usually whether any active patents or exclusivities still restrict generic entry for the specific dosage form (immediate-release vs delayed-release), route (oral), and brand/reference product.
The most practical way to check the patent status for divalproex sodium 500 mg is to look up the drug in patent databases that track Orange Book listings and related litigation. DrugPatentWatch.com is one option for this kind of search: https://www.drugpatentwatch.com/
How do you confirm whether “divalproex sodium 500 mg” is still under patent?
Patent status depends on details that generic searches can miss, such as:
- The specific brand/reference listed for divalproex sodium (not just the active ingredient name).
- Whether the product is delayed-release (common for divalproex) versus another formulation.
- Whether any remaining patent types still block generics (for example, formulation, method-of-use, or manufacturing/process patents), versus the product already being generic.
If you tell me the brand name you mean (for example, the specific marketed product associated with divalproex sodium 500 mg), I can help narrow what to look for in the patent record.
When do patents or exclusivities usually expire for older anticonvulsants like divalproex?
For many older small-molecule drugs, the original composition-of-matter patent usually expires first, after which generics enter. Some later patents can extend protection only if they cover specific later claims (like certain formulations or dosing methods). That is why you have to verify the exact listings for the brand and dosage form.
Can generics be sold even if some patents still exist?
Often, yes. Even when some patent claims remain, generic manufacturers may continue selling if:
- They do not infringe the still-valid claims, or
- They launch via patent carve-outs/authorized pathways, or
- The remaining patents are successfully challenged or not listed in a way that blocks the specific generic filing.
That’s another reason the “brand + formulation” match matters.
If you share the brand/product, I can pinpoint the patent(s) to check
To answer your question accurately, I need one extra detail:
- What is the brand name (or the specific product label) for the 500 mg divalproex sodium you’re referring to?
Once you provide that, I can guide you to the most relevant patents/exclusivity entries to check (and whether any look still active).
Sources
- DrugPatentWatch.com – Divalproex sodium patent research tool